PURPOSE: Poorly controlled pain is common in advanced cancer. The objective of this article was to synthesize the evidence on the effectiveness of pain-focused interventions in this population. METHODS: We searched MEDLINE, CINAHL, PsycINFO, Cochrane, and DARE from 2000 through December 2011. We included prospective, controlled health care intervention studies in advanced cancer populations, focusing on pain. RESULTS: Nineteen studies met the inclusion criteria; most focused on nurse-led patient-centered interventions. In all, 9 (47%) of the 19 studies found a significant effect on pain. The most common intervention type was patient/caregiver education, in 17 (89%) of 19 studies, 7 of which demonstrated a significant decrease in pain. CONCLUSIONS: We found moderate strength of evidence that pain in advanced cancer can be improved using health care interventions, particularly nurse-led patient-centered interventions.
PURPOSE: Poorly controlled pain is common in advanced cancer. The objective of this article was to synthesize the evidence on the effectiveness of pain-focused interventions in this population. METHODS: We searched MEDLINE, CINAHL, PsycINFO, Cochrane, and DARE from 2000 through December 2011. We included prospective, controlled health care intervention studies in advanced cancer populations, focusing on pain. RESULTS: Nineteen studies met the inclusion criteria; most focused on nurse-led patient-centered interventions. In all, 9 (47%) of the 19 studies found a significant effect on pain. The most common intervention type was patient/caregiver education, in 17 (89%) of 19 studies, 7 of which demonstrated a significant decrease in pain. CONCLUSIONS: We found moderate strength of evidence that pain in advanced cancer can be improved using health care interventions, particularly nurse-led patient-centered interventions.
Entities:
Keywords:
advanced cancer; end of life; health care interventions; pain; quality improvement; systematic review
Authors: Robert Swarm; Amy Pickar Abernethy; Doralina L Anghelescu; Costantino Benedetti; Craig D Blinderman; Barry Boston; Charles Cleeland; Nessa Coyle; Oscar A Deleon-Casasola; June G Eilers; Betty Ferrell; Nora A Janjan; Sloan Beth Karver; Michael H Levy; Maureen Lynch; Natalie Moryl; Barbara A Murphy; Suzanne A Nesbit; Linda Oakes; Eugenie A Obbens; Judith A Paice; Michael W Rabow; Karen L Syrjala; Susan Urba; Sharon M Weinstein Journal: J Natl Compr Canc Netw Date: 2010-09 Impact factor: 11.908
Authors: Michael J Fisch; Ju-Whei Lee; Matthias Weiss; Lynne I Wagner; Victor T Chang; David Cella; Judith B Manola; Lori M Minasian; Worta McCaskill-Stevens; Tito R Mendoza; Charles S Cleeland Journal: J Clin Oncol Date: 2012-04-16 Impact factor: 44.544
Authors: Wendy H Oldenmenger; Peter A E Sillevis Smitt; Cees A G M van Montfort; Pleun J de Raaf; Carin C D van der Rijt Journal: Pain Date: 2011-09-08 Impact factor: 6.961
Authors: Greta G Cummings; Susan Armijo Olivo; Patricia D Biondo; Carla R Stiles; Ozden Yurtseven; Robin L Fainsinger; Neil A Hagen Journal: J Pain Symptom Manage Date: 2011-03-12 Impact factor: 3.612
Authors: Evelien H van der Peet; Marieke H J van den Beuken-van Everdingen; Jacob Patijn; Harry C Schouten; Maarten van Kleef; Annemie M Courtens Journal: Support Care Cancer Date: 2008-12-23 Impact factor: 3.603
Authors: Laura S Porter; Gregory Samsa; Jennifer L Steel; Laura C Hanson; Thomas W LeBlanc; Janet Bull; Stacy Fischer; Francis J Keefe Journal: Clin Trials Date: 2019-02-19 Impact factor: 2.486
Authors: Catherine J Evans; Lucy Ison; Clare Ellis-Smith; Caroline Nicholson; Alessia Costa; Adejoke O Oluyase; Eve Namisango; Anna E Bone; Lisa Jane Brighton; Deokhee Yi; Sarah Combes; Sabrina Bajwah; Wei Gao; Richard Harding; Paul Ong; Irene J Higginson; Matthew Maddocks Journal: Milbank Q Date: 2019-03 Impact factor: 4.911